| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.77B | +7.0% |
| Cost of Revenue | $1.76B | +3.0% |
| Gross Profit | $1.02B | +14.7% |
| R&D Expense | $38.8M | +7.8% |
| SG&A Expense | $587.5M | +10.1% |
| Operating Income | $404.2M | +22.8% |
| Pre-tax Income | $319.1M | +6.3% |
| Income Tax | $95.7M | +38.4% |
| Net Income | $205.3M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $102.0M | +41.6% |
| Accounts Receivable | $385.2M | +2.9% |
| Inventory | $392.9M | -5.8% |
| Current Assets | $997.7M | +0.9% |
| Total Assets | $3.83B | +2.0% |
| Current Liabilities | $620.1M | +3.1% |
| Long-term Debt | $1.02B | -16.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $330.5M | +54.2% |
| Capital Expenditures | $48.2M | +19.7% |
| Investing Cash Flow | -$62.2M | +66.2% |
| Financing Cash Flow | -$219.7M | -3007.5% |
| Free Cash Flow | $282.3M | +62.1% |
| -8.3% |
| EPS (Basic) | $3.39 | -8.4% |
| EPS (Diluted) | $3.36 | -8.9% |
| Total Liabilities |
| $2.18B |
| -7.8% |
| Stockholders' Equity | $1.61B | +19.0% |